VG Acquisition Corp.

VG Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Richard Charles Nicholas Branson on February 19, 2020 and is headquartered in New York, NY. Redemption Price: 10. Warrant Coverage: 1/3.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.

The Special Purpose Acquisition Company (SPAC) begins trading publicly. During this phase, the SPAC looks for a target company to merge with.

SEARCHING PHASE

The SPAC announces which company it will be acquiring (and taking public).

PREVIOUS PHASE

Investors and shareholders will meet to approve the acquisition.

CURRENT PHASE

The company is the latest to go public via a SPAC deal. 23andMe, the direct-to-consumer genetic testing company headquartered in Sunnyvale, California, popped on its stock market debut Thursday.

23andMe jumps on stock market debut, as privacy concerns about genetic testing abound

Congratulations, 23andMe. You're a public stock now!

Why 23andMe Stock Just Jumped 10%

Shares of consumer genetics company 23andMe rose about 17% in their trading debut Thursday, after the provider of home DNA test kits went public via a merger with Richard Branson's special-purpose acquisition corporation, or SPAC, VG Acquisition Corp.

IPO Report: 23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC

Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17 Combined Company to Trade on Nasdaq Under Ticker “ME” Commencing June 17

23andMe Successfully Closes its Business Combination with VG Acquisition Corp.

Businessman Richard Branson and 23andMe are making headlines after Branson's Virgin Acquisition Group will complete its merger this week. The post VGAC Stock: Everything You Need to Know About Richard Branson, 23andMe and This Week's SPAC Merger appeared first on InvestorPlace.

VGAC Stock: Everything You Need to Know About Richard Branson, 23andMe and This Week's SPAC Merger

NEW YORK, June 10, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group ("VGAC" or the "Company") today announced that its shareholders voted to approve the previously announced merger agreement with 23andMe, Inc. ("23andMe") at VGAC's extraordinary general meeting of shareholders (the "Special Meeting") held earlier today. More than 87% of the votes cast at the Special Meeting were in favor of the approval of the merger agreement.

Virgin Group's VG Acquisition Corp. Shareholders Approve Business Combination with 23andMe, Inc.

SoFi Technologies

It can be difficult to value a SPAC, even after it announces a merger agreement.

How Can You Value a SPAC Stock Before It Completes Its Merger?

AppHarvest

Churchill Capital Corp IV

The stocks are down, but are the businesses still intact?

These 3 SPAC Stocks Have Crashed 40% Off Their Highs: Is Now the Time to Consider Buying?

NEW YORK and SUNNYVALE, Calif., June 2, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group ("VGAC" or the "Company"), reminds its shareholders to vote on the Company's proposed business combination with 23andMe, Inc. ("23andMe"), a leading consumer genetics and research company, and the related proposals that will come before VGAC's extraordinary general meeting of shareholders (the "Special Meeting").

Virgin Group's VG Acquisition Corp. Reminds Stockholders to Vote on its Proposed Business Combination with 23andMe, Inc.

NEW YORK, May 28, 2021 /PRNewswire/ -- VG Acquisition Corp. (the "Company") today announced it received a notice on May 25, 2021 from the New York Stock Exchange ("NYSE") indicating that as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Quarterly Report"), the Company no longer complies with the continued listing requirements set forth in Section 802.01E of the NYSE Listed Company Manual. The notice has no immediate impact on the listing of the Company's securities, which will continue to trade on the NYSE, subject to the Company's compliance with other applicable continued listing requirements.

VG Acquisition Corp. Receives Expected Notification from NYSE Related to Delayed Quarterly Report

NEW YORK and SUNNYVALE, Calif., May 26, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC) ("VGAC" and, after the Domestication (as defined below) and following its name change to 23andMe Holding Co., "New 23andMe") today announced that, upon the Domestication and the consummation of its pending business combination (the "Business Combination") with 23andMe, Inc. ("23andMe"), New 23andMe Class A Common Stock and New 23andMe Warrants (each as defined below) will be listed on The Nasdaq Global Select Market ("Nasdaq").

New 23andMe to Trade on Nasdaq as "ME"

NEW YORK and SUNNYVALE, Calif., May 17, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced that the date of its extraordinary general meeting of shareholders to vote on its proposed business combination with 23andMe, Inc., a leading consumer genetics and research company, will be June 10, 2021.

Virgin Group's VG Acquisition Corp. Announces Date of Shareholders Meeting in Connection with its Pending Business Combination with 23andMe

NEW YORK and SUNNYVALE, Calif., May 5, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced that it has filed an amended registration statement on Form S-4 in connection with its pending business combination with 23andMe, Inc., a leading consumer genetics and research company.

Virgin Group's VG Acquisition Corp. Filed Amended Form S-4 in Connection with its Pending Business Combination with 23andMe

VGAC, the SPAC created by Sir Richard Branson, quickly spiked to over $17.50 prior to announcing the intended merger. Investors appeared to be underwhelmed by 23andMe, sending the SPAC back down to $10, an attractive entry point for long-term investors.

VG Acquisition Corp.: 23andMe Could Be A Massive But Risky Winner

Social Capital Hedosophia Holdings Corp. V

Apex Technology Acquisition Corporation

BowX Acquisition Corp

Social Capital Hedosophia Hlds

Pershing Square Tontine Holdings

Soaring Eagle Acquisition Corp - Unit

With SPACs, you can get in on the ground floor of good -- or bad -- ideas, or you can just bet on the guys holding the checkbook. The post 8 Major Players in the SPAC Game to Watch appeared first on InvestorPlace.

8 Major Players in the SPAC Game to Watch

If 23andme is worth $3.5 billion, it's based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits. The post VG Acquisition Stock: The Value's in the DNA Vault, Not the Spit Kits appeared first on InvestorPlace.

VG Acquisition Stock: The Value's in the DNA Vault, Not the Spit Kits

Here's why long-term investors might want to take a look at this genetics company before it's officially public.

Is 23andMe a Buy Before Its SPAC Merger Is Done?

This consumer-facing company could have massive potential.

Here's Why I Bought Shares of This Genetics Company

Two of these have identified their targets, and the other has some interesting possibilities.

SPACs to Watch: Lucid Motors, 23andMe, and More

VGAC stock will keep losing steam since markets expected an EV of financial services merger target rather than a genetic testing company. The post As 23andMe Flounders, Buying Into VG Acquisition Looks Like a Terrible Idea appeared first on InvestorPlace.

As 23andMe Flounders, Buying Into VG Acquisition Looks Like a Terrible Idea

CoreLogic

RigNet

NEW YORK, March 11, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP1500 Broadway, 16th Floor New York, NY  10036 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com CoreLogic, Inc. (NYSE: CLGX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CoreLogic, Inc. (NYSE: CLGX) in connection with the proposed acquisition of the company by funds managed by Stone Point Capital and Insight Partners.

SHAREHOLDER ALERT: WeissLaw LLP Reminds CLGX, VGAC, SNCA, and RNET Shareholders About Its Ongoing Investigations

With VGAC stock having dropped around $10 per share, now's the time to enter a position before the 23andMe deal closes. The post As Shares Continue to Slide, Buy VGAC Stock Ahead of 23andMe Merger appeared first on InvestorPlace.

As Shares Continue to Slide, Buy VGAC Stock Ahead of 23andMe Merger

It's been a month since VG Acquisition announced it was merging with 23andMe. VGAC stock has lost 40% of its value.

Should VG Acquisition Stock Be Bought on Weakness?

Maxar Technologies

Snowflake

We all know that fortune favors the bold. Here are three opportunities to capitalize off of courage.

3 Revolutionary Stocks That Could Make You Rich in 2021

HighCape Capital Acquisition Corp.

Holicity

A rocket company, a 3-D capture software company, and two biotechs are about to hit the public markets. Smart investors can get in now via special purpose acquisition companies.

News for VG Acquisition Corp. Stock (VGAC)